Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?
Aliment Pharmacol Ther
.
2021 Aug;54(3):341-342.
doi: 10.1111/apt.16482.
Authors
Sailish Honap
1
2
,
Polychronis Pavlidis
1
2
,
Peter M Irving
1
2
Affiliations
1
IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
2
School of Immunology and Microbial Sciences, King's College, London, UK.
PMID:
34236096
DOI:
10.1111/apt.16482
No abstract available
Publication types
Editorial
Comment
MeSH terms
Colitis, Ulcerative* / drug therapy
Humans
Piperidines / therapeutic use
Pyrimidines / therapeutic use
Pyrroles / therapeutic use
Substances
Piperidines
Pyrimidines
Pyrroles
tofacitinib